Cargando…

Pharmacological inhibition of USP7 promotes antitumor immunity and contributes to colon cancer therapy

BACKGROUND: Effectiveness of clinical therapy such as chemotherapy for solid tumors is limited by acquired drug resistance and side effects. Available antitumor immunity methods showed promising prospect of cancer therapy. However, more drug targets for boosting antitumor immunity still need to be e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Changqing, Zhu, Xiaojue, Xu, Peiqi, Li, Yonghao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339463/ https://www.ncbi.nlm.nih.gov/pubmed/30697058 http://dx.doi.org/10.2147/OTT.S182806

Ejemplares similares

Growth hormone receptor promotes breast cancer progression via the BRAF/MEK/ERK signaling pathway
por: Zhu, Xiaojue, et al.
Publicado: (2020)

Selective Inhibition of USP7
por: Menard, Robert, et al.
Publicado: (2012)

Pharmacological inhibition of USP7 suppresses growth and metastasis of melanoma cells in vitro and in vivo
por: Xiang, Minmin, et al.
Publicado: (2021)

USP18 is crucial for IFN-γ-mediated inhibition of B16 melanoma tumorigenesis and antitumor immunity
por: Hong, Bangxing, et al.
Publicado: (2014)

Serine Metabolism Regulates YAP Activity Through USP7 in Colon Cancer
por: Zhao, Xiaoya, et al.
Publicado: (2021)

Derepressing of STAT3 and USP7 contributes to resistance of DLBCL to EZH2 inhibition
por: He, Chenyun, et al.
Publicado: (2023)

USP7 inhibits Wnt/β-catenin signaling through promoting stabilization of Axin
por: Ji, Lei, et al.
Publicado: (2019)

USP7 Promotes deubiquitination and stabilization of MyD88 to enhance immune responses
por: Zhang, Na, et al.
Publicado: (2022)

USP7 substrates identified by proteomics analysis reveal the specificity of USP7
por: Nie, Litong, et al.
Publicado: (2022)

USP15 stabilizes MDM2 to mediate cancer cell survival and inhibit antitumor T cell responses
por: Zou, Qiang, et al.
Publicado: (2014)

E2F7 Transcriptionally Inhibits MicroRNA-199b Expression to Promote USP47, Thereby Enhancing Colon Cancer Tumor Stem Cell Activity and Promoting the Occurrence of Colon Cancer
por: Guo, Xiong, et al.
Publicado: (2021)

Fbw7 and Usp28 – enemies and allies
por: Taranets, Lyudmyla, et al.
Publicado: (2015)

A feedforward circuit shaped by ECT2 and USP7 contributes to breast carcinogenesis
por: Zhang, Qi, et al.
Publicado: (2020)

USP7 and USP47 deubiquitinases regulate NLRP3 inflammasome activation
por: Palazón‐Riquelme, Pablo, et al.
Publicado: (2018)

Inhibition of USP7 upregulates USP22 and activates its downstream cancer-related signaling pathways in human cancer cells
por: Zhang, Keqiang, et al.
Publicado: (2023)

USP7: Novel Drug Target in Cancer Therapy
por: Wang, Zhiru, et al.
Publicado: (2019)

Identifying USPs regulating immune signals in Drosophila: USP2 deubiquitinates Imd and promotes its degradation by interacting with the proteasome
por: Engel, Elodie, et al.
Publicado: (2014)

Neuroinflammation inhibition by small-molecule targeting USP7 noncatalytic domain for neurodegenerative disease therapy
por: Zhang, Xiao-Wen, et al.
Publicado: (2022)

USP7 inhibition induces apoptosis in glioblastoma by enhancing ubiquitination of ARF4
por: Pan, Tingzheng, et al.
Publicado: (2021)

The deubiquitinase USP7 promotes HNSCC progression via deubiquitinating and stabilizing TAZ
por: Li, Jin, et al.
Publicado: (2022)

Molecular mechanism for the substrate recognition of USP7
por: Cheng, Jingdong, et al.
Publicado: (2015)

Targeting melanoma residual disease by USP7
por: Vishnoi, Monika, et al.
Publicado: (2018)

Highlights in USP7 inhibitors for cancer treatment
por: Oliveira, Rita I., et al.
Publicado: (2022)

USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c
por: Yao, Ye, et al.
Publicado: (2022)

USP7/HAUSP Promotes the Sequence-Specific DNA Binding Activity of p53
por: Sarkari, Feroz, et al.
Publicado: (2010)

Correction: IL-17A weakens the antitumor immunity by inhibiting apoptosis of MDSCs in Lewis lung carcinoma bearing mice
por: Wang, Juan, et al.
Publicado: (2022)

Pharmacologic Activation of p53 Triggers Viral Mimicry Response Thereby Abolishing Tumor Immune Evasion and Promoting Antitumor Immunity
por: Zhou, Xiaolei, et al.
Publicado: (2021)

High USP32 expression contributes to cancer progression and is correlated with immune infiltrates in hepatocellular carcinoma
por: Xiu, Mengxi, et al.
Publicado: (2023)

Polyamine blockade promotes antitumor immunity
por: Hayes, Candace S, et al.
Publicado: (2014)

Mucin 4 mutation is associated with tumor mutation burden and promotes antitumor immunity in colon cancer patients
por: Peng, Linglong, et al.
Publicado: (2021)

Overexpression of the Ubiquitin Specific Proteases USP43, USP41, USP27x and USP6 in Osteosarcoma Cell Lines: Inhibition of Osteosarcoma Tumor Growth and Lung Metastasis Development by the USP Antagonist PR619
por: Lavaud, Mélanie, et al.
Publicado: (2021)

Inhibition of USP7 suppresses advanced glycation end-induced cell cycle arrest and senescence of human umbilical vein endothelial cells through ubiquitination of p53: USP7 inhibits ubiquitination of p53
por: Li, Xu, et al.
Publicado: (2022)

TIP60 governs the auto-ubiquitination of UHRF1 through USP7 dissociation from the UHRF1/USP7 complex
por: Ahmad, Tanveer, et al.
Publicado: (2021)

Cancer Cell Membrane Camouflaged Mesoporous Silica Nanoparticles Combined with Immune Checkpoint Blockade for Regulating Tumor Microenvironment and Enhancing Antitumor Therapy
por: Zhao, Peiqi, et al.
Publicado: (2021)

Correction: USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c
por: Yao, Ye, et al.
Publicado: (2023)

Ubiquitin-specific Protease-7 Inhibition Impairs Tip60-dependent Foxp3 + T-regulatory Cell Function and Promotes Antitumor Immunity
por: Wang, Liqing, et al.
Publicado: (2016)

HSCARG downregulates NF-κB signaling by interacting with USP7 and inhibiting NEMO ubiquitination
por: Li, T, et al.
Publicado: (2014)

USP14 de-ubiquitinates vimentin and miR-320a modulates USP14 and vimentin to contribute to malignancy in gastric cancer cells
por: Zhu, Ying, et al.
Publicado: (2016)

USP24 promotes drug resistance during cancer therapy
por: Wang, Shao-An, et al.
Publicado: (2021)

TSPY1 suppresses USP7-mediated p53 function and promotes spermatogonial proliferation
por: Shen, Ying, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_tdvqvk8lno67obrgtv2047akra